TURKAN PASALİ KİLİT, KEVSER ONBASİ, FİLİZ OZYİGİT
Clinical and Experimental Health Sciences - 2020;10(1):40-45
Objective: Treatment adherence is regarded as an important factor in achieving optimal outcomes across many disease states. The purpose of this study was to evaluate the adherence of osteoporosis patients and determinate the factors affecting adherence. Methods: A total number of 150 patients with osteoporosis were included in the study. Demographic data, anthropometric measurements and laboratory results of the patients were recorded. In addition, the survey questions including patients’ marital status, education levels, income status, smoking and alcohol consumption habits, exercise levels, dietary habits, fracture histories, menopausal ages, treatments they received, medication side effects and treatment adherences were asked by a face-to-face interview method. Results: The mean age of the 150 patients included in the study was 65.6±9.8 years. Ninety-four percent of the patients were female. Patients who received osteoporosis treatment with oral agents had poorer adherence to treatment than patients receiving subcutaneous or intravenous agents (p=0.003). Other factors had no effect on adherence. Conclusion: Treatment adherence, which is one of the concepts related to the principles of rational drug use, is an important part of treatment success. The choice of agents administered subcutaneously or intravenously in the treatment of osteoporosis will result in better adherence with treatment than oral agents.
